These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 32781508)

  • 1. Sex-Specific Features of Calcific Aortic Valve Disease.
    Summerhill VI; Moschetta D; Orekhov AN; Poggio P; Myasoedova VA
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
    Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the use of biomarkers in calcific aortic valve disease.
    Beckmann E; Grau JB; Sainger R; Poggio P; Ferrari G
    J Heart Valve Dis; 2010 Jul; 19(4):441-52. PubMed ID: 20845891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification.
    Vieceli Dalla Sega F; Fortini F; Cimaglia P; Marracino L; Tonet E; Antonucci A; Moscarelli M; Campo G; Rizzo P; Ferrari R
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.
    Jung JJ; Razavian M; Challa AA; Nie L; Golestani R; Zhang J; Ye Y; Russell KS; Robinson SP; Heistad DD; Sadeghi MM
    J Nucl Med; 2015 Jun; 56(6):933-8. PubMed ID: 25908827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcification and extracellular matrix dysregulation in human postmortem and surgical aortic valves.
    Gomez-Stallons MV; Tretter JT; Hassel K; Gonzalez-Ramos O; Amofa D; Ollberding NJ; Mazur W; Choo JK; Smith JM; Kereiakes DJ; Yutzey KE
    Heart; 2019 Nov; 105(21):1616-1621. PubMed ID: 31171628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.
    Pasipoularides A
    J Cardiovasc Transl Res; 2016 Apr; 9(2):102-18. PubMed ID: 26891845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting vasoactive peptides for managing calcific aortic valve disease.
    Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
    Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteogenesis in calcified aortic valve disease: From histopathological observation towards molecular understanding.
    Liu X; Xu Z
    Prog Biophys Mol Biol; 2016 Nov; 122(2):156-161. PubMed ID: 26971958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.
    van der Ven CF; Wu PJ; Tibbitt MW; van Mil A; Sluijter JP; Langer R; Aikawa E
    Clin Sci (Lond); 2017 Feb; 131(3):181-195. PubMed ID: 28057890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcific aortic stenosis.
    Lindman BR; Clavel MA; Mathieu P; Iung B; Lancellotti P; Otto CM; Pibarot P
    Nat Rev Dis Primers; 2016 Mar; 2():16006. PubMed ID: 27188578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
    Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E
    J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcific aortic valve disease: is it another face of atherosclerosis?
    Sathyamurthy I; Alex S
    Indian Heart J; 2015; 67(5):503-6. PubMed ID: 26432749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-free optical biomarkers detect early calcific aortic valve disease in a wild-type mouse model.
    Tandon I; Johns S; Woessner A; Perez J; Cross D; Ozkizilcik A; Muldoon TJ; Vallurupalli S; Padala M; Quinn KP; Balachandran K
    BMC Cardiovasc Disord; 2020 Dec; 20(1):521. PubMed ID: 33308143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
    Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
    Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
    Guddeti RR; Patil S; Ahmed A; Sharma A; Aboeata A; Lavie CJ; Alla VM
    Prog Cardiovasc Dis; 2020; 63(4):496-502. PubMed ID: 32526213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.
    Gomez-Stallons MV; Wirrig-Schwendeman EE; Hassel KR; Conway SJ; Yutzey KE
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1398-405. PubMed ID: 27199449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoC-III is a novel inducer of calcification in human aortic valves.
    Schlotter F; de Freitas RCC; Rogers MA; Blaser MC; Wu PJ; Higashi H; Halu A; Iqbal F; Andraski AB; Rodia CN; Kuraoka S; Wen JR; Creager M; Pham T; Hutcheson JD; Body SC; Kohan AB; Sacks FM; Aikawa M; Singh SA; Aikawa E
    J Biol Chem; 2021; 296():100193. PubMed ID: 33334888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-Related Discordance Between Aortic Valve Calcification and Hemodynamic Severity of Aortic Stenosis: Is Valvular Fibrosis the Explanation?
    Simard L; Côté N; Dagenais F; Mathieu P; Couture C; Trahan S; Bossé Y; Mohammadi S; Pagé S; Joubert P; Clavel MA
    Circ Res; 2017 Feb; 120(4):681-691. PubMed ID: 27879282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
    Yadgir S; Johnson CO; Aboyans V; Adebayo OM; Adedoyin RA; Afarideh M; Alahdab F; Alashi A; Alipour V; Arabloo J; Azari S; Barthelemy CM; Benziger CP; Berman AE; Bijani A; Carrero JJ; Carvalho F; Daryani A; Durães AR; Esteghamati A; Farid TA; Farzadfar F; Fernandes E; Filip I; Gad MM; Hamidi S; Hay SI; Ilesanmi OS; Naghibi Irvani SS; Jürisson M; Kasaeian A; Kengne AP; Khan AR; Kisa A; Kisa S; Kolte D; Manafi N; Manafi A; Mensah GA; Mirrakhimov EM; Mohammad Y; Mokdad AH; Negoi RI; Thi Nguyen HL; Nguyen TH; Nixon MR; Otto CM; Patel S; Pilgrim T; Radfar A; Rawaf DL; Rawaf S; Rawasia WF; Rezapour A; Roever L; Saad AM; Saadatagah S; Senthilkumaran S; Sliwa K; Tesfay BE; Tran BX; Ullah I; Vaduganathan M; Vasankari TJ; Wolfe CDA; Yonemoto N; Roth GA;
    Circulation; 2020 May; 141(21):1670-1680. PubMed ID: 32223336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.